TP53 and cancer: TRIM25 has been reported to target key regulatory proteins such as p53, PTEN, and Keap1 for degradation, thereby exerting a fundamental influence on the control of cancer cell proliferation, metastasis, and the mediation of chemotherapy resistance 37,39,40.